GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Institutional Ownership

BerGenBio ASA (OSL:BGBIO) Institutional Ownership : 1.58% (As of Jun. 23, 2024)


View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BerGenBio ASA's institutional ownership is 1.58%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BerGenBio ASA's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BerGenBio ASA's Float Percentage Of Total Shares Outstanding is 0.00%.

BerGenBio ASA Institutional Ownership Historical Data

The historical data trend for BerGenBio ASA's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BerGenBio ASA Institutional Ownership Chart

BerGenBio ASA Historical Data

The historical data trend for BerGenBio ASA can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.41 0.41 0.29 0.28 0.90 1.28 1.28 1.65 1.62 1.58

BerGenBio ASA Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

BerGenBio ASA (OSL:BGBIO) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (OSL:BGBIO) » Definitions » Institutional Ownership
Comparable Companies
OSL:CIRCA OSL:EXTX OSL:TRMED OSL:LYTIX OSL:ABS OSL:PCIB OSL:ABTEC OSL:SOFTX OSL:CRNA OSL:HBC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
0RU5:UK 7BG0:Germany
Address
Mollendalsbakken 9, Bergen, NOR, 5009
Website
https://www.bergenbio.com
BerGenBio ASA is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is d is curently being developed in STK11 mutated NSCLC and severe respiratory infections including COVID-19. .

BerGenBio ASA (OSL:BGBIO) Headlines

No Headlines